Cannasouth Ltd
NZX:CBD
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| NZ |
|
Cannasouth Ltd
NZX:CBD
|
32.4m NZD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
997.4B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
551.5B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
281B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.8B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
224.3B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
280.3B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.6T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
150.6B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
97.3B EUR |
Loading...
|
Market Distribution
| Min | -2 988.2% |
| 30th Percentile | -2.1% |
| Median | 4.2% |
| 70th Percentile | 9.4% |
| Max | 106.9% |
Other Profitability Ratios
Cannasouth Ltd
Glance View
Cannasouth Ltd. is a biopharmaceutical, research and development company, which develops medicinal cannabis products. The firm focuses on the commercial development of the medically beneficial attributes of cannabinoid compounds such as Cannabidiol (CBD), Tetrahydrocannabinol (THC) and associated chemical structures that are produced by the cannabis plant.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Cannasouth Ltd is -922.3%, which is above its 3-year median of -3 414.5%.
Over the last 3 years, Cannasouth Ltd’s Net Margin has increased from -2 655% to -922.3%. During this period, it reached a low of -5 848.3% on Dec 31, 2022 and a high of -316.3% on Jun 30, 2022.
